Sorina Carabeth
Psychiatry · San Luis Obispo, CANPI 1912039496
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $11,341 of the $13,800 with a category attached, or 82.2%. 24 manufacturers reported payments, led by AbbVie at 42.2% of the total. Among psychiatry clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 522 payments — averaging $26.44 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$6K
- Takeda Pharmaceuticals U.S.A., Inc.$2K
- Bausch Health US, LLC$1K
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$774
- Axsome Therapeutics, Inc.$648
- Alkermes, Inc.$540
- plus $3K from 18 others
What the payments were for
- Speaking & faculty fees$2,40017%
- Travel & lodging$430%
- Food & beverage$11,34182%
- Education$160%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 197 | $5,819 |
| Takeda Pharmaceuticals U.S.A., Inc. | 94 | $1,683 |
| Bausch Health US, LLC | 62 | $1,076 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 19 | $774 |
| Axsome Therapeutics, Inc. | 18 | $648 |
| Alkermes, Inc. | 14 | $540 |
| Otsuka America Pharmaceutical, Inc. | 12 | $432 |
| Ironshore Pharmaceuticals Inc. | 11 | $403 |
| Eisai Inc. | 14 | $291 |
| Lundbeck LLC | 12 | $254 |
| Almatica Pharma LLC | 12 | $243 |
| Idorsia Pharmaceuticals US Inc | 7 | $235 |
| Sunovion Pharmaceuticals Inc. | 4 | $227 |
| Merck | 12 | $221 |
| Jazz Pharmaceuticals Inc. | 6 | $185 |
| Tris Pharma Inc | 8 | $180 |
| Corium, LLC | 6 | $154 |
| Neurocrine Biosciences, Inc. | 1 | $138 |
| Vanda Pharmaceuticals Inc. | 4 | $95 |
| Supernus Pharmaceuticals, Inc. | 3 | $59 |
| Merz North America, Inc. | 2 | $54 |
| Indivior Inc. | 2 | $40 |
| Teva Pharmaceuticals USA, Inc. | 1 | $31 |
| Shire North American Group Inc | 1 | $20 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$13,800 in reported general payments places this provider in the 95th percentile of 4,954 psychiatry providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| VraylarCariprazine Hcl | 34 | $46,747 |
| TrintellixVortioxetine Hydrobromide | 29 | $27,030 |
| AplenzinBupropion Hbr | 13 | $25,570 |
| Vilazodone Hcl | 54 | $8,469 |
| Bupropion XlBupropion Hcl | 51 | $1,978 |
| Quetiapine Fumarate | 47 | $1,614 |
| Zolpidem Tartrate | 29 | $1,196 |
| Duloxetine Hcl | 15 | $1,153 |
| Paroxetine ErParoxetine Hcl | 13 | $1,133 |
| Alprazolam | 131 | $1,111 |
| Liothyronine Sodium | 25 | $955 |
| Desvenlafaxine Succinate ErDesvenlafaxine Succinate | 12 | $921 |
| Doxepin Hcl | 40 | $792 |
| Fluoxetine Hcl | 69 | $751 |
| Lamotrigine | 42 | $660 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieVraylar | $5,819 | $46,74734 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Trintellix | $1,683 | $27,03029 claims |
| Bausch Health US, LLCAplenzin | $1,076 | $25,57013 claims |
| Almatica Pharma LLCSertraline Hcl | $243 | $47427 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 4,954 psychiatry providers in California.
Other psychiatry in San Luis Obispo
- Gustavo AlvaOrange$5.8M
- John KooSan Francisco$3M
- Jason KelloggIrvine$2.7M
- Jonathan MeyerSan Diego$2.3M
- Charles Tuan-Tu NguyenIrvine$2.1M
- Manoj WaikarLos Gatos$1.9M
- Gerald MaguireSan Juan Capistraco$1.8M
- Salima BrillmanSunnyvale$1.4M
- Bibi DasStanford$1.4M
- Konstantinos TripodisBurbank$1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.